Is it wise to give immunoglobulin prophylaxis against respiratory syncytial virus infection?;Er det klogt at give immunglobulinprofylakse mod respiratorisk syncytialvirusinfektion?

Ugeskrift for Laeger

Volumn 163, Issue 47, 2001, Pages 6607-

  Greisen, G ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; MONOCLONAL ANTIBODY;

HUMAN; IMMUNOPROPHYLAXIS; NOTE; PASSIVE IMMUNIZATION; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VENTILATOR; VIRUS INFECTION; ARTICLE; COST OF ILLNESS; DRUG COST; ECONOMICS; NEWBORN; PREMATURITY;

ANTIBODIES, MONOCLONAL; COST OF ILLNESS; DRUG COSTS; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFANT, PREMATURE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0035915206     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (2)

1. RSV propylaxis - The story so far
2. Infection with RS-virus in infants with extremely low gestational age or birth weight